Precigen, Inc. Common Stock (PGEN) News
Latest headlines that mention PGEN, newest first · each headline opens the original publisher
- Last price
- $6.38
- Day change
- -11.26%
- Next earnings
- 2026-11-12
PGEN headlines
latest coveragePAPZIMEOS revenue surged 145.8% sequentially as company posts first profitable quarter.
Focused on gene and cellular therapies, this biotech firm reported a notable insider sale amid a year of rapid share price gains.
Focused on gene and cell therapies, this biotech innovator reported a notable insider sale amid a year of exceptional share price gains.
PGEN news alerts
Get an alert by email or push when a new headline mentions PGEN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.